Protagonist Therapeutics (PTGX)

• Market cap: $5.02B
• 1 day: 0.02%
• 5 days: -8.35%
• 1 month: -9.42%
• 3 months: 19.66%
• 6 months: 53.41%
• Year to date: -7.98%
• 1 year: 119.12%
• 5 years: 289.04%
• 10 years: 585.64%
• Sector: Healthcare
• Industry: Biotechnology

About: Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

Employees: 128